Surgical fix for failed lung valve treatment shows promise in early trial

NCT ID NCT07682168

Not yet recruiting Disease control Sponsor: Rocco Bilancia Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This trial investigates a surgical procedure to divide the fissure between lung lobes in people with COPD and emphysema who did not improve after endobronchial valve treatment. The goal is to see if the surgery is safe and feasible, potentially leading to better lung collapse and function. The study enrolls up to 15 patients and tracks success rates, complications, and costs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: surgical division of the interlobar fissure
What this could lead to: If safe and effective, this procedure could offer a new option for COPD patients who do not respond to standard lung volume reduction treatments.
What could go wrong: This is a small early safety study with only 15 participants, so results may not apply broadly. The surgery carries risks like any thoracoscopic procedure, including infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease pulmonary emphysema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) EMPHYSEMA LUNG VOLUME REDUCTION SURGERY

More trials for these conditions

Other studies related to the condition(s) this trial covers.